Issue 3/2023
Functional Molecules-based Approaches in Cancer Therapeutics
Content (19 Articles)
Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics
Anupam Dhasmana, Swati Dhasmana, Shafiul Haque, Everardo Cobos, Murali M. Yallapu, Subhash C. Chauhan
Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, Nirmal Kumar Katiyar, Eiman Aleem, Saurav Goel
New progress of tuberculosis scar carcinoma
Wenwen Sun, Yujin Liu, Lishu Zhao, Hao Wang, Li Ye, Xinyue Liu, Kandi Xu, Yu Chen, Lin Fan
Potential biomarkers for immunotherapy in non-small-cell lung cancer
Xing Wang, Ziyun Qiao, Beatrice Aramini, Dong Lin, Xiaolong Li, Jiang Fan
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, Ira Spector
Oral delivery of RNAi for cancer therapy
Humayra Afrin, Renu Geetha Bai, Raj Kumar, Sheikh Shafin Ahmad, Sandeep K. Agarwal, Md Nurunnabi
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
Mahrou Vahabi, Bilal Dehni, Inés Antomás, Elisa Giovannetti, Godefridus J. Peters
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Wen-Jing Goh, Mingliang You, Siddaiah Chandra Nayak, Lu Chen, Gautam Sethi, Kanchugarakoppal Subbegowda Rangappa, Lingzhi Wang
Natural compounds targeting nuclear receptors for effective cancer therapy
Mangala Hegde, Sosmitha Girisa, Nikunj Naliyadhara, Aviral Kumar, Mohammed S. Alqahtani, Mohamed Abbas, Chakrabhavi Dhananjaya Mohan, Sudha Warrier, Kam Man Hui, Kanchugarakoppal S. Rangappa, Gautam Sethi, Ajaikumar B. Kunnumakkara
Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy
Prateeksha Prateeksha, Vivek K. Sharma, Shiv M. Singh, Minaxi Sharma, Deepti Diwan, Abd El-Latif Hesham, Sanjay Guleria, Quang D. Nguyen, Vijai K. Gupta, Brahma N. Singh
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics
Archana Sharma, Diksha Sharma, Neha Saini, Sunil V. Sharma, Vijay Kumar Thakur, Ramesh K. Goyal, Prabodh Chander Sharma
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions
Chunxue Zhang, Yaru Sheng, Xiao Sun, Yudong Wang
Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy
Rainer J. Klement, Reinhart A. Sweeney
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
Irene van der Haar Àvila, Britt Windhouwer, Sandra J. van Vliet
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, Tara Farhadi, Osman Hesami, Amin Iranpanah, Kassidy Webber, Anupam Bishayee
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
Akira Ooki, Hiroki Osumi, Koshiro Fukuda, Kensei Yamaguchi